AHAFCD LLC – Trademark Portfolio

Entity Type: 16

AHAFCD LLC holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 33 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 30 trademarks are registered and 1 is pending. Notable registered marks include PB8, RENEWX, IMMUNE C, FIBER WELL, and VITAFUSION. The owner is based in Bohemia, NY.

3900 Veterans Memorial Highway

Suite 200

Bohemia, NY 11716

36 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (36 results)

Trademark Classifications

AHAFCD LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (33 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (6 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does AHAFCD LLC have?

AHAFCD LLC has 36 U.S. trademarks filed with the USPTO. Of these, 30 registered, 1 pending, 5 abandoned.

What trademark classes does AHAFCD LLC file in?

AHAFCD LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AHAFCD LLC's most well-known trademarks?

AHAFCD LLC's registered trademark portfolio includes well-known marks such as PB8, RENEWX, IMMUNE C, FIBER WELL, and VITAFUSION. These are among 30 currently registered trademarks in the portfolio.

What is AHAFCD LLC's trademark registration success rate?

AHAFCD LLC has a 86% trademark registration rate, with 30 out of 35 resolved applications resulting in successful registration. Currently, 1 application is pending review.